Anti?vascular Endothelial Growth Factor Therapy and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Anti?vascular Endothelial Growth Factor Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti?vascular Endothelial Growth Factor Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti?vascular Endothelial Growth Factor Therapy Overall Market Size
2.1 Global Anti?vascular Endothelial Growth Factor Therapy Market Size: 2021 VS 2028
2.2 Global Anti?vascular Endothelial Growth Factor Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anti?vascular Endothelial Growth Factor Therapy Players in Global Market
3.2 Top Global Anti?vascular Endothelial Growth Factor Therapy Companies Ranked by Revenue
3.3 Global Anti?vascular Endothelial Growth Factor Therapy Revenue by Companies
3.4 Top 3 and Top 5 Anti?vascular Endothelial Growth Factor Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Anti?vascular Endothelial Growth Factor Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti?vascular Endothelial Growth Factor Therapy Players in Global Market
3.6.1 List of Global Tier 1 Anti?vascular Endothelial Growth Factor Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Anti?vascular Endothelial Growth Factor Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Anti?vascular Endothelial Growth Factor Therapy Market Size Markets, 2021 & 2028
4.1.2 Extraction Injection
4.1.3 Precharge Injection
4.2 By Type - Global Anti?vascular Endothelial Growth Factor Therapy Revenue & Forecasts
4.2.1 By Type - Global Anti?vascular Endothelial Growth Factor Therapy Revenue, 2017-2022
4.2.2 By Type - Global Anti?vascular Endothelial Growth Factor Therapy Revenue, 2023-2028
4.2.3 By Type - Global Anti?vascular Endothelial Growth Factor Therapy Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti?vascular Endothelial Growth Factor Therapy Market Size, 2021 & 2028
5.1.2 Macular Degeneration
5.1.3 Nacular Edema
5.1.4 Uveitis
5.1.5 Retinal Vein Occlusion
5.2 By Application - Global Anti?vascular Endothelial Growth Factor Therapy Revenue & Forecasts
5.2.1 By Application - Global Anti?vascular Endothelial Growth Factor Therapy Revenue, 2017-2022
5.2.2 By Application - Global Anti?vascular Endothelial Growth Factor Therapy Revenue, 2023-2028
5.2.3 By Application - Global Anti?vascular Endothelial Growth Factor Therapy Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Anti?vascular Endothelial Growth Factor Therapy Market Size, 2021 & 2028
6.2 By Region - Global Anti?vascular Endothelial Growth Factor Therapy Revenue & Forecasts
6.2.1 By Region - Global Anti?vascular Endothelial Growth Factor Therapy Revenue, 2017-2022
6.2.2 By Region - Global Anti?vascular Endothelial Growth Factor Therapy Revenue, 2023-2028
6.2.3 By Region - Global Anti?vascular Endothelial Growth Factor Therapy Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Anti?vascular Endothelial Growth Factor Therapy Revenue, 2017-2028
6.3.2 US Anti?vascular Endothelial Growth Factor Therapy Market Size, 2017-2028
6.3.3 Canada Anti?vascular Endothelial Growth Factor Therapy Market Size, 2017-2028
6.3.4 Mexico Anti?vascular Endothelial Growth Factor Therapy Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Anti?vascular Endothelial Growth Factor Therapy Revenue, 2017-2028
6.4.2 Germany Anti?vascular Endothelial Growth Factor Therapy Market Size, 2017-2028
6.4.3 France Anti?vascular Endothelial Growth Factor Therapy Market Size, 2017-2028
6.4.4 U.K. Anti?vascular Endothelial Growth Factor Therapy Market Size, 2017-2028
6.4.5 Italy Anti?vascular Endothelial Growth Factor Therapy Market Size, 2017-2028
6.4.6 Russia Anti?vascular Endothelial Growth Factor Therapy Market Size, 2017-2028
6.4.7 Nordic Countries Anti?vascular Endothelial Growth Factor Therapy Market Size, 2017-2028
6.4.8 Benelux Anti?vascular Endothelial Growth Factor Therapy Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Anti?vascular Endothelial Growth Factor Therapy Revenue, 2017-2028
6.5.2 China Anti?vascular Endothelial Growth Factor Therapy Market Size, 2017-2028
6.5.3 Japan Anti?vascular Endothelial Growth Factor Therapy Market Size, 2017-2028
6.5.4 South Korea Anti?vascular Endothelial Growth Factor Therapy Market Size, 2017-2028
6.5.5 Southeast Asia Anti?vascular Endothelial Growth Factor Therapy Market Size, 2017-2028
6.5.6 India Anti?vascular Endothelial Growth Factor Therapy Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Anti?vascular Endothelial Growth Factor Therapy Revenue, 2017-2028
6.6.2 Brazil Anti?vascular Endothelial Growth Factor Therapy Market Size, 2017-2028
6.6.3 Argentina Anti?vascular Endothelial Growth Factor Therapy Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Anti?vascular Endothelial Growth Factor Therapy Revenue, 2017-2028
6.7.2 Turkey Anti?vascular Endothelial Growth Factor Therapy Market Size, 2017-2028
6.7.3 Israel Anti?vascular Endothelial Growth Factor Therapy Market Size, 2017-2028
6.7.4 Saudi Arabia Anti?vascular Endothelial Growth Factor Therapy Market Size, 2017-2028
6.7.5 UAE Anti?vascular Endothelial Growth Factor Therapy Market Size, 2017-2028
7 Players Profiles
7.1 Regeneron Pharmaceuticals (Eylea)
7.1.1 Regeneron Pharmaceuticals (Eylea) Corporate Summary
7.1.2 Regeneron Pharmaceuticals (Eylea) Business Overview
7.1.3 Regeneron Pharmaceuticals (Eylea) Anti?vascular Endothelial Growth Factor Therapy Major Product Offerings
7.1.4 Regeneron Pharmaceuticals (Eylea) Anti?vascular Endothelial Growth Factor Therapy Revenue in Global Market (2017-2022)
7.1.5 Regeneron Pharmaceuticals (Eylea) Key News
7.2 Genentech
7.2.1 Genentech Corporate Summary
7.2.2 Genentech Business Overview
7.2.3 Genentech Anti?vascular Endothelial Growth Factor Therapy Major Product Offerings
7.2.4 Genentech Anti?vascular Endothelial Growth Factor Therapy Revenue in Global Market (2017-2022)
7.2.5 Genentech Key News
7.3 Kanghong Pharmaceutical
7.3.1 Kanghong Pharmaceutical Corporate Summary
7.3.2 Kanghong Pharmaceutical Business Overview
7.3.3 Kanghong Pharmaceutical Anti?vascular Endothelial Growth Factor Therapy Major Product Offerings
7.3.4 Kanghong Pharmaceutical Anti?vascular Endothelial Growth Factor Therapy Revenue in Global Market (2017-2022)
7.3.5 Kanghong Pharmaceutical Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Anti?vascular Endothelial Growth Factor Therapy Market Opportunities & Trends in Global Market
Table 2. Anti?vascular Endothelial Growth Factor Therapy Market Drivers in Global Market
Table 3. Anti?vascular Endothelial Growth Factor Therapy Market Restraints in Global Market
Table 4. Key Players of Anti?vascular Endothelial Growth Factor Therapy in Global Market
Table 5. Top Anti?vascular Endothelial Growth Factor Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Anti?vascular Endothelial Growth Factor Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Anti?vascular Endothelial Growth Factor Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Anti?vascular Endothelial Growth Factor Therapy Product Type
Table 9. List of Global Tier 1 Anti?vascular Endothelial Growth Factor Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti?vascular Endothelial Growth Factor Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Anti?vascular Endothelial Growth Factor Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Anti?vascular Endothelial Growth Factor Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Anti?vascular Endothelial Growth Factor Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Anti?vascular Endothelial Growth Factor Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Anti?vascular Endothelial Growth Factor Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Anti?vascular Endothelial Growth Factor Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2023-2028
Table 30. Regeneron Pharmaceuticals (Eylea) Corporate Summary
Table 31. Regeneron Pharmaceuticals (Eylea) Anti?vascular Endothelial Growth Factor Therapy Product Offerings
Table 32. Regeneron Pharmaceuticals (Eylea) Anti?vascular Endothelial Growth Factor Therapy Revenue (US$, Mn), (2017-2022)
Table 33. Genentech Corporate Summary
Table 34. Genentech Anti?vascular Endothelial Growth Factor Therapy Product Offerings
Table 35. Genentech Anti?vascular Endothelial Growth Factor Therapy Revenue (US$, Mn), (2017-2022)
Table 36. Kanghong Pharmaceutical Corporate Summary
Table 37. Kanghong Pharmaceutical Anti?vascular Endothelial Growth Factor Therapy Product Offerings
Table 38. Kanghong Pharmaceutical Anti?vascular Endothelial Growth Factor Therapy Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Anti?vascular Endothelial Growth Factor Therapy Segment by Type in 2021
Figure 2. Anti?vascular Endothelial Growth Factor Therapy Segment by Application in 2021
Figure 3. Global Anti?vascular Endothelial Growth Factor Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Anti?vascular Endothelial Growth Factor Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anti?vascular Endothelial Growth Factor Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti?vascular Endothelial Growth Factor Therapy Revenue in 2021
Figure 8. By Type - Global Anti?vascular Endothelial Growth Factor Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Anti?vascular Endothelial Growth Factor Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Anti?vascular Endothelial Growth Factor Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Anti?vascular Endothelial Growth Factor Therapy Revenue Market Share, 2017-2028
Figure 12. US Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Anti?vascular Endothelial Growth Factor Therapy Revenue Market Share, 2017-2028
Figure 16. Germany Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Anti?vascular Endothelial Growth Factor Therapy Revenue Market Share, 2017-2028
Figure 24. China Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Anti?vascular Endothelial Growth Factor Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Anti?vascular Endothelial Growth Factor Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. Regeneron Pharmaceuticals (Eylea) Anti?vascular Endothelial Growth Factor Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Genentech Anti?vascular Endothelial Growth Factor Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Kanghong Pharmaceutical Anti?vascular Endothelial Growth Factor Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
